---
document_datetime: 2025-08-19 15:35:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aucatzyl-epar-all-authorised-presentations_en.pdf
document_name: aucatzyl-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7141427
conversion_datetime: 2025-12-19 00:20:35.377499
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical Form     | Route of Administration   | Immediate Packaging   | Content (concentration)     | Pack size                                                                                                               |
|------------------|-------------------|-----------------|-------------------------|---------------------------|-----------------------|-----------------------------|-------------------------------------------------------------------------------------------------------------------------|
| EU/1/25/1951/001 | Aucatzyl          | 410 x 10⁶ cells | Dispersion for infusion | Intravenous use           | bag (EVA)             | 10 ml + 10-20 ml + 30-70 ml | Patient specific pack to dose with 410 × 10⁶ cells: 1 bag of 10 ml + 0 to 2 bags of 10- 20 ml + 1 to 6 bags of 30-70 ml |